Intraocular implants and methods and kits therefor

US12551376B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12551376-B2
Application numberUS-202217866429-A
CountryUS
Kind codeB2
Filing dateJul 15, 2022
Priority dateJun 26, 2006
Publication dateFeb 17, 2026
Grant dateFeb 17, 2026

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Devices, methods and kits are described for reducing intraocular pressure. The devices include a support that is implantable within Schlemm's canal and maintains the patency of the canal without substantially interfering with transmural fluid flow across the canal. The devices utilize the natural drainage process of the eye and can be implanted with minimal trauma to the eye. Kits include a support and an introducer for implanting the support within Schlemm's canal. Methods include implanting a support within Schlemm's canal, wherein the support is capable of maintaining the patency of the canal without substantial interference with transmural fluid flow across the canal.

First claim

Opening claim text (preview).

The invention claimed is: 1 . A kit for reducing intraocular pressure, comprising: a support configured to be implanted circumferentially within Schlemm's canal to maintain patency of at least a portion of Schlemm's canal; an introducer configured to position the support within Schlemm's canal; and a dilating device configured to inject fluid into Schlemm's canal. 2 . The kit of claim 1 , wherein the support is configured to allow transmural fluid flow across Schlemm's canal. 3 . The kit of claim 1 , wherein the support comprises an arcuate member. 4 . The kit of claim 3 , wherein the arcuate member comprises a radius of curvature of about 3 mm to about 8 mm. 5 . The kit of claim 3 , wherein the arcuate member comprises a radius of curvature that is smaller than a radius of curvature of Schlemm's canal. 6 . The kit of claim 1 , wherein the support is configured to extend about one quarter of the way around Schlemm's canal. 7 . The kit of claim 1 , wherein the support is configured to extend about one half of the way around Schlemm's canal. 8 . The kit of claim 1 , wherein the support comprises at least one fenestration. 9 . The kit of claim 8 , wherein the support comprises a plurality of fenestrations. 10 . The kit of claim 1 , wherein the support is non-tubular. 11 . The kit of claim 1 , wherein the support comprises a shape memory material. 12 . The kit of claim 1 , wherein the support is a first support, the kit further comprising at least one second support. 13 . The kit of claim 12 , wherein the first support and the at least one second support are configured to be implanted within different eyes of a patient. 14 . The kit of claim 1 , wherein the introducer comprises a cannula configured to guide the support to Schlemm's canal. 15 . The kit of claim 14 , wherein the cannula is tubular. 16 . The kit of claim 14 , wherein the introducer further comprises a rod configured to advance the support into Schlemm's canal. 17 . The kit of claim 16 , wherein the rod is positioned within a lumen of the cannula. 18 . The kit of claim 17 , wherein the support is positioned at distal end of the rod within the lumen of the cannula. 19 . The kit of claim 1 , wherein the fluid comprises a high viscosity fluid. 20 . The kit of claim 19 , wherein the fluid comprises sodium hyaluronate.

Assignees

Inventors

Classifications

  • implantable in, or in contact with, the eye, e.g. ocular inserts · CPC title

  • Means for introducing or releasing pharmaceutical products into the body · CPC title

  • using shape memory or superelastic materials, e.g. nitinol · CPC title

  • bioabsorbable · CPC title

  • Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment (drainage implants in general A61M27/002) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12551376B2 cover?
Devices, methods and kits are described for reducing intraocular pressure. The devices include a support that is implantable within Schlemm's canal and maintains the patency of the canal without substantially interfering with transmural fluid flow across the canal. The devices utilize the natural drainage process of the eye and can be implanted with minimal trauma to the eye. Kits include a sup…
Who is the assignee on this patent?
Sight Sciences Inc
What technology area does this patent fall under?
Primary CPC classification A61F9/00781. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Feb 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).